<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet href="https://rss.buzzsprout.com/styles.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:psc="http://podlove.org/simple-chapters" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <atom:link href="https://rss.buzzsprout.com/659329.rss" rel="self" type="application/rss+xml" />
  <atom:link href="https://pubsubhubbub.appspot.com/" rel="hub" xmlns="http://www.w3.org/2005/Atom" />
  <title>The PPD Podcast</title>

  <lastBuildDate>Sun, 29 Mar 2026 21:13:00 -0400</lastBuildDate>
  <link>https://ppdpodcast.buzzsprout.com</link>
  <language>en-us</language>
  <copyright>© 2026 The PPD Podcast</copyright>
  <podcast:locked>yes</podcast:locked>
    <podcast:guid>469b17d8-5f69-579b-80f1-9c71682fe196</podcast:guid>
  <itunes:author>PPD</itunes:author>
  <itunes:type>episodic</itunes:type>
  <itunes:explicit>false</itunes:explicit>
  <description><![CDATA[<p>Interviews and insights with thought leaders from the PPD clinical research business of Thermo Fisher Scientific.</p>]]></description>
  <generator>Buzzsprout (https://www.buzzsprout.com)</generator>
  <itunes:owner>
    <itunes:name>PPD</itunes:name>
  </itunes:owner>
  <image>
     <url>https://storage.buzzsprout.com/9tpzcbozfhw76eioi0r7lygsagt1?.jpg</url>
     <title>The PPD Podcast</title>
     <link></link>
  </image>
  <itunes:image href="https://storage.buzzsprout.com/9tpzcbozfhw76eioi0r7lygsagt1?.jpg" />
  <itunes:category text="Science">
    <itunes:category text="Life Sciences" />
  </itunes:category>
  <itunes:category text="Health &amp; Fitness">
    <itunes:category text="Medicine" />
  </itunes:category>
  <itunes:category text="Science" />
  <item>
    <itunes:title>From Lab to Launch by Qualio: Revolutionizing clinical trial outsourcing</itunes:title>
    <title>From Lab to Launch by Qualio: Revolutionizing clinical trial outsourcing</title>
    <itunes:summary><![CDATA[Learn how FSP partnerships help sponsors scale expertise, maintain oversight, and improve clinical trial performance. ]]></itunes:summary>
    <description><![CDATA[<p>Learn how FSP partnerships help sponsors scale expertise, maintain oversight, and improve clinical trial performance.</p>]]></description>
    <content:encoded><![CDATA[<p>Learn how FSP partnerships help sponsors scale expertise, maintain oversight, and improve clinical trial performance.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/18782221-from-lab-to-launch-by-qualio-revolutionizing-clinical-trial-outsourcing.mp3" length="17592471" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/27ug54uzv8mq1gvb61swnibpd60g?.jpg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18782221</guid>
    <pubDate>Tue, 03 Mar 2026 10:00:00 -0500</pubDate>
    <itunes:duration>1464</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Exploring Biomarker Testing in Clinical Research</itunes:title>
    <title>Exploring Biomarker Testing in Clinical Research</title>
    <itunes:summary><![CDATA[In this podcast, PPD expert Cyrille Bonhomme discusses the development of vaccine assays and how to accelerate the timelines for development. He explores different types of assays available and the tools and specific expertise needed to develop high throughput and robust assays. ]]></itunes:summary>
    <description><![CDATA[<p>In this podcast, PPD expert Cyrille Bonhomme discusses the development of vaccine assays and how to accelerate the timelines for development. He explores different types of assays available and the tools and specific expertise needed to develop high throughput and robust assays.</p>]]></description>
    <content:encoded><![CDATA[<p>In this podcast, PPD expert Cyrille Bonhomme discusses the development of vaccine assays and how to accelerate the timelines for development. He explores different types of assays available and the tools and specific expertise needed to develop high throughput and robust assays.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/18591344-exploring-biomarker-testing-in-clinical-research.mp3" length="12374697" type="audio/mpeg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18591344</guid>
    <pubDate>Thu, 29 Jan 2026 12:00:00 -0500</pubDate>
    <itunes:duration>1028</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>The Importance of Monitoring Assay Performance and Maintenance</itunes:title>
    <title>The Importance of Monitoring Assay Performance and Maintenance</title>
    <itunes:summary><![CDATA[In this podcast, Atul Chaudhari discuss the challenges and solutions in monitoring assay performance. He explores the benefits of qualification and validation when developing cell and virus neutralization assays for high throughput clinical testing and the best approach to maintain assay performance long-term without affecting the quality. Speaker: Atul Chaudhari, Principal Scientist, PPD Clinical Research Services, Thermo Fisher Scientific ]]></itunes:summary>
    <description><![CDATA[<p>In this podcast, Atul Chaudhari discuss the challenges and solutions in monitoring assay performance. He explores the benefits of qualification and validation when developing cell and virus neutralization assays for high throughput clinical testing and the best approach to maintain assay performance long-term without affecting the quality.</p><p>Speaker: Atul Chaudhari, Principal Scientist, PPD Clinical Research Services, Thermo Fisher Scientific</p>]]></description>
    <content:encoded><![CDATA[<p>In this podcast, Atul Chaudhari discuss the challenges and solutions in monitoring assay performance. He explores the benefits of qualification and validation when developing cell and virus neutralization assays for high throughput clinical testing and the best approach to maintain assay performance long-term without affecting the quality.</p><p>Speaker: Atul Chaudhari, Principal Scientist, PPD Clinical Research Services, Thermo Fisher Scientific</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/17558693-the-importance-of-monitoring-assay-performance-and-maintenance.mp3" length="13310295" type="audio/mpeg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17558693</guid>
    <pubDate>Thu, 24 Jul 2025 14:00:00 -0400</pubDate>
    <itunes:duration>1106</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Lupus Fireside Chat with Dr. Leonard Calabrese</itunes:title>
    <title>Lupus Fireside Chat with Dr. Leonard Calabrese</title>
    <itunes:summary></itunes:summary>
    <description></description>
    <content:encoded></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/14912809-lupus-fireside-chat-with-dr-leonard-calabrese.mp3" length="23227361" type="audio/mpeg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14912809</guid>
    <pubDate>Thu, 18 Apr 2024 10:00:00 -0400</pubDate>
    <itunes:duration>1930</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Key considerations for biotechs using next-generation contract GMP/CMC Laboratories</itunes:title>
    <title>Key considerations for biotechs using next-generation contract GMP/CMC Laboratories</title>
    <itunes:summary><![CDATA[Exponential growth in the biotech and pharmaceutical industries plus the unprecedented expansion of different pharmaceutical therapies make it critical for companies to partner with a strategic contract laboratory to help meet all their outsourcing needs. Learn how GMP and CMC labs can help fulfill biotechs' needs with the latest platforms, technologies and instruments in this podcast with PPD’s Cathy Liloila and Jie Ding.  Speakers: Jie Ding - Senior Director, PPD® Laboratory Services, GMP L...]]></itunes:summary>
    <description><![CDATA[<p>Exponential growth in the biotech and pharmaceutical industries plus the unprecedented expansion of different pharmaceutical therapies make it critical for companies to partner with a strategic contract laboratory to help meet all their outsourcing needs. Learn how GMP and CMC labs can help fulfill biotechs&apos; needs with the latest platforms, technologies and instruments in this podcast with PPD’s Cathy Liloila and Jie Ding.<br/><br/>Speakers:</p><ul><li><b>Jie Ding - </b>Senior Director, PPD® Laboratory Services, GMP Lab</li><li><b>Catherine Liloia - </b>Senior Director, PPD® Laboratory Services, GMP Lab</li></ul>]]></description>
    <content:encoded><![CDATA[<p>Exponential growth in the biotech and pharmaceutical industries plus the unprecedented expansion of different pharmaceutical therapies make it critical for companies to partner with a strategic contract laboratory to help meet all their outsourcing needs. Learn how GMP and CMC labs can help fulfill biotechs&apos; needs with the latest platforms, technologies and instruments in this podcast with PPD’s Cathy Liloila and Jie Ding.<br/><br/>Speakers:</p><ul><li><b>Jie Ding - </b>Senior Director, PPD® Laboratory Services, GMP Lab</li><li><b>Catherine Liloia - </b>Senior Director, PPD® Laboratory Services, GMP Lab</li></ul>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/14147531-key-considerations-for-biotechs-using-next-generation-contract-gmp-cmc-laboratories.mp3" length="12303743" type="audio/mpeg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14147531</guid>
    <pubDate>Thu, 14 Dec 2023 14:00:00 -0500</pubDate>
    <itunes:duration>1022</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>The BioInsights Podcast</itunes:title>
    <title>The BioInsights Podcast</title>
    <itunes:summary></itunes:summary>
    <description></description>
    <content:encoded></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/13032023-the-bioinsights-podcast.mp3" length="18058997" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/e4qnnr914yne9gn45lu0rw2b9458?.jpg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-13032023</guid>
    <pubDate>Tue, 13 Jun 2023 12:00:00 -0400</pubDate>
    <itunes:duration>1500</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Vaccine and Vaccine Assay Development</itunes:title>
    <title>Vaccine and Vaccine Assay Development</title>
    <itunes:summary><![CDATA[In this podcast, PPD expert Cyrille Bonhomme discusses the development of vaccine assays and how to accelerate the timelines for development. He explores different types of assays available and the tools and specific expertise needed to develop high throughput and robust assays.  Speaker: Cyrille Bonhomme, PhD, Director, PPD Laboratory Services, Vaccine Sciences Lab PPD, Part of Thermo Fisher Scientific ]]></itunes:summary>
    <description><![CDATA[<p>In this podcast, PPD expert Cyrille Bonhomme discusses the development of vaccine assays and how to accelerate the timelines for development. He explores different types of assays available and the tools and specific expertise needed to develop high throughput and robust assays. </p><p><b>Speaker: </b>Cyrille Bonhomme, PhD, Director, PPD Laboratory Services, Vaccine Sciences Lab PPD, Part of Thermo Fisher Scientific</p>]]></description>
    <content:encoded><![CDATA[<p>In this podcast, PPD expert Cyrille Bonhomme discusses the development of vaccine assays and how to accelerate the timelines for development. He explores different types of assays available and the tools and specific expertise needed to develop high throughput and robust assays. </p><p><b>Speaker: </b>Cyrille Bonhomme, PhD, Director, PPD Laboratory Services, Vaccine Sciences Lab PPD, Part of Thermo Fisher Scientific</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/11195940-vaccine-and-vaccine-assay-development.mp3" length="11941408" type="audio/mpeg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-11195940</guid>
    <pubDate>Wed, 24 Aug 2022 09:00:00 -0400</pubDate>
    <itunes:duration>1165</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Bioanalytical Assays for Gene Therapy Programs</itunes:title>
    <title>Bioanalytical Assays for Gene Therapy Programs</title>
    <itunes:summary><![CDATA[In this podcast, PPD expert Cathy Vrentas discusses how to leverage bioanalytical assays for gene therapy programs, key considerations in the development of these assays, and how the unique nature of gene therapies impact the development and maintenance of bioanalytical assays.   Speaker: Catherine (Cathy) Vrentas, senior research scientist, PPD® Laboratories bioanalytical lab ]]></itunes:summary>
    <description><![CDATA[<p>In this podcast, PPD expert Cathy Vrentas discusses how to leverage bioanalytical assays for gene therapy programs, key considerations in the development of these assays, and how the unique nature of gene therapies impact the development and maintenance of bioanalytical assays.</p><p> </p><p>Speaker: Catherine (Cathy) Vrentas, senior research scientist, PPD® Laboratories bioanalytical lab</p>]]></description>
    <content:encoded><![CDATA[<p>In this podcast, PPD expert Cathy Vrentas discusses how to leverage bioanalytical assays for gene therapy programs, key considerations in the development of these assays, and how the unique nature of gene therapies impact the development and maintenance of bioanalytical assays.</p><p> </p><p>Speaker: Catherine (Cathy) Vrentas, senior research scientist, PPD® Laboratories bioanalytical lab</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/10731452-bioanalytical-assays-for-gene-therapy-programs.mp3" length="10225503" type="audio/mpeg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-10731452</guid>
    <pubDate>Fri, 03 Jun 2022 09:00:00 -0400</pubDate>
    <itunes:duration>849</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Oncology Imperatives: Accelerating Startup in Early Phase Oncology Studies</itunes:title>
    <title>Oncology Imperatives: Accelerating Startup in Early Phase Oncology Studies</title>
    <itunes:summary><![CDATA[Dave Frakes, LuAnne Novello and Joseph Brennan discuss the topic of accelerating startup in early phase oncology studies in this most recent PPD podcast.  ]]></itunes:summary>
    <description><![CDATA[<p>Dave Frakes, LuAnne Novello and Joseph Brennan discuss the topic of accelerating startup in early phase oncology studies in this most recent PPD podcast. </p>]]></description>
    <content:encoded><![CDATA[<p>Dave Frakes, LuAnne Novello and Joseph Brennan discuss the topic of accelerating startup in early phase oncology studies in this most recent PPD podcast. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/9513752-oncology-imperatives-accelerating-startup-in-early-phase-oncology-studies.mp3" length="8945841" type="audio/mpeg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-9513752</guid>
    <pubDate>Mon, 08 Nov 2021 15:00:00 -0500</pubDate>
    <itunes:duration>743</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Improving Recruitment and Retention in Dermatology</itunes:title>
    <title>Improving Recruitment and Retention in Dermatology</title>
    <itunes:summary></itunes:summary>
    <description></description>
    <content:encoded></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/8762396-improving-recruitment-and-retention-in-dermatology.mp3" length="10277334" type="audio/mpeg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8762396</guid>
    <pubDate>Fri, 25 Jun 2021 09:00:00 -0400</pubDate>
    <podcast:soundbite startTime="84.969" duration="27.5" />
    <itunes:duration>854</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Oncology Imperatives: Decentralized Clinical Trial Models</itunes:title>
    <title>Oncology Imperatives: Decentralized Clinical Trial Models</title>
    <itunes:summary><![CDATA[Dave Frakes, Mariah Baltezegar, Simon Coggins and Tim Rich discuss decentralized trial models in oncology clinical trials. ]]></itunes:summary>
    <description><![CDATA[<p>Dave Frakes, Mariah Baltezegar, Simon Coggins and Tim Rich discuss decentralized trial models in oncology clinical trials.</p>]]></description>
    <content:encoded><![CDATA[<p>Dave Frakes, Mariah Baltezegar, Simon Coggins and Tim Rich discuss decentralized trial models in oncology clinical trials.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/8533880-oncology-imperatives-decentralized-clinical-trial-models.mp3" length="12165060" type="audio/mpeg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8533880</guid>
    <pubDate>Mon, 17 May 2021 09:00:00 -0400</pubDate>
    <itunes:duration>1011</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Oncology Imperatives: Adaptive Trial Design</itunes:title>
    <title>Oncology Imperatives: Adaptive Trial Design</title>
    <itunes:summary></itunes:summary>
    <description></description>
    <content:encoded></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/7948624-oncology-imperatives-adaptive-trial-design.mp3" length="10282098" type="audio/mpeg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-7948624</guid>
    <pubDate>Thu, 18 Feb 2021 14:00:00 -0500</pubDate>
    <itunes:duration>854</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>3</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>The Patient Pathway in CAR-T: Part I</itunes:title>
    <title>The Patient Pathway in CAR-T: Part I</title>
    <itunes:summary><![CDATA[A discussion with Lymphoma Coalition CEO, Lorna Warwick, and PPD cell and gene therapy experts Dr. Panteli Theocharous and Ryan Michalek. ]]></itunes:summary>
    <description><![CDATA[<p>A discussion with Lymphoma Coalition CEO, Lorna Warwick, and PPD cell and gene therapy experts Dr. Panteli Theocharous and Ryan Michalek.</p>]]></description>
    <content:encoded><![CDATA[<p>A discussion with Lymphoma Coalition CEO, Lorna Warwick, and PPD cell and gene therapy experts Dr. Panteli Theocharous and Ryan Michalek.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/6693662-the-patient-pathway-in-car-t-part-i.mp3" length="9289596" type="audio/mpeg" />
    <itunes:author>PPD</itunes:author>
    <guid isPermaLink="false">Buzzsprout-6693662</guid>
    <pubDate>Fri, 04 Dec 2020 13:00:00 -0500</pubDate>
    <itunes:duration>771</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>PPD Laboratories: Bioassay Challenges</itunes:title>
    <title>PPD Laboratories: Bioassay Challenges</title>
    <itunes:summary><![CDATA[A discussion of the latest bioassay tools and techniques and their impact on drug development. Host Randy Buckwalter is joined by experts Cathy Liloia and Becky Garshick of PPD Laboratories. ]]></itunes:summary>
    <description><![CDATA[<p>A discussion of the latest bioassay tools and techniques and their impact on drug development. Host Randy Buckwalter is joined by experts Cathy Liloia and Becky Garshick of PPD Laboratories.</p>]]></description>
    <content:encoded><![CDATA[<p>A discussion of the latest bioassay tools and techniques and their impact on drug development. Host Randy Buckwalter is joined by experts Cathy Liloia and Becky Garshick of PPD Laboratories.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/659329/episodes/5787145-ppd-laboratories-bioassay-challenges.mp3" length="12578756" type="audio/mpeg" />
    <itunes:author>PPD BioTech</itunes:author>
    <guid isPermaLink="false">Buzzsprout-5787145</guid>
    <pubDate>Wed, 07 Oct 2020 13:00:00 -0400</pubDate>
    <itunes:duration>1046</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>1</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
</channel>
</rss>
